Careteq Ltd. (AU:CTQ)
ASX:CTQ
Want to see AU:CTQ full AI Analyst Report?
Top Page
Careteq Ltd.
(Sydney:CTQ)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.01
▲(20.00% Upside)
Action:ReiteratedDate:04/25/26
The score is held down primarily by weak financial resilience: rising leverage and persistently negative operating/free cash flow despite improving profitability. Technicals provide some support with price above key moving averages, but extremely overbought RSI and a flat/negative MACD reduce confidence. Valuation is also constrained by negative earnings (negative P/E) and no dividend data.
Positive Factors
Revenue Scale-up
Material top-line scale from a very small base to A$7.6m provides durable evidence of product-market fit and expanding customer adoption. This enlarged revenue base supports operating leverage, enables reinvestment in product and sales, and improves the company's ability to pursue profitable growth over the next 2–6 months.
Negative Factors
Rising Leverage
A sharp increase in debt materially weakens the balance sheet and reduces financial flexibility. Higher leverage elevates interest and refinancing risk, limiting the company's ability to absorb shocks or invest, and increases the probability of needing external funding or dilutive capital if cash generation falters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Scale-up
Material top-line scale from a very small base to A$7.6m provides durable evidence of product-market fit and expanding customer adoption. This enlarged revenue base supports operating leverage, enables reinvestment in product and sales, and improves the company's ability to pursue profitable growth over the next 2–6 months.
Read all positive factors
Careteq Ltd. (CTQ) vs. iShares MSCI Australia ETF (EWA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)84.31K
Price to Earnings (P/E)―
Beta (1Y)0.23
Revenue Growth-48.09%
EPS Growth87.88%
CountryAU
Employees24
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding296,183,560
10 Day Avg. Volume0
30 Day Avg. Volume84,309
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)2.61
Price to Sales (P/S)0.52
P/FCF Ratio-4.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Careteq Ltd. Business Overview & Revenue Model
Company Description
Careteq Limited, a health-tech company, provides software as a service (SaaS)-based assistive living technology and services that focuses on meeting the needs in the health, aged, and home care sectors worldwide. The company develops and commercia...
How the Company Makes Money
Careteq Ltd. generates revenue primarily through the sale of its healthcare technology solutions, including smart assistive devices, subscriptions for cloud-based health monitoring services, and licensing agreements. Additional revenue streams may...
Careteq Ltd. Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
35
Negative
Cash Flow
28
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.67M | 7.62M | 7.23M | 4.98M | 4.43M | 735.44K |
| Gross Profit | 645.22K | 1.50M | 6.74M | -2.44M | 4.14M | -2.03M |
| EBITDA | -614.76K | 275.62K | -826.62K | -2.65M | -5.90M | -5.06M |
| Net Income | -199.98K | -72.20K | -2.67M | -4.33M | -5.25M | -5.23M |
Balance Sheet | ||||||
| Total Assets | 4.44M | 5.94M | 6.82M | 7.57M | 8.02M | 12.23M |
| Cash, Cash Equivalents and Short-Term Investments | 681.80K | 1.05M | 1.25M | 1.85M | 4.50M | 8.90M |
| Total Debt | 2.30M | 2.37M | 192.98K | 961.96K | 0.00 | 75.28K |
| Total Liabilities | 3.20M | 4.42M | 3.30M | 4.02M | 1.72M | 2.61M |
| Stockholders Equity | 1.24M | 1.52M | 1.97M | 2.14M | 6.30M | 9.61M |
Cash Flow | ||||||
| Free Cash Flow | -624.11K | -804.93K | -2.59M | -3.42M | -4.54M | -1.52M |
| Operating Cash Flow | -546.57K | -732.06K | -1.30M | -2.53M | -4.52M | -1.50M |
| Investing Cash Flow | -180.51K | 119.16K | -570.80K | -799.63K | -256.83K | -23.21K |
| Financing Cash Flow | 537.96K | 400.96K | 1.27M | 687.55K | 8.81M | 1.50M |
Careteq Ltd. Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.01
Negative
<0.01
Positive
Market Momentum
>-0.01
Negative
39.25
Neutral
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and above the 200-day MA of <0.01, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 39.25 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.
Careteq Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | AU$15.55M | -2.48 | -578.72% | ― | 43.55% | 26.03% | |
43 Neutral | AU$67.93M | -6.64 | -59.96% | ― | ― | ― | |
43 Neutral | AU$33.44M | -3.13 | -1009.84% | ― | 13.69% | 7.57% | |
42 Neutral | ― | -2.35 | -14.47% | ― | -48.09% | 87.88% | |
41 Neutral | AU$4.23M | -1.98 | 20.02% | ― | -5.76% | 8.00% |
* Healthcare Sector Average
AU:CTQ
Careteq Ltd.
0.01
<0.01
16.67%
AU:GLH
Global Health Limited
0.07
-0.02
-20.00%
AU:SHG
Singular Health Group Ltd
0.22
-0.07
-25.86%
AU:ICR
InteliCare Holdings Limited
0.03
0.02
150.00%
AU:PCK
PainChek Ltd
0.16
-0.19
-54.29%
Careteq Ltd. Corporate Events
Careteq Secures Full Shareholder Backing as All General Meeting Resolutions Pass
Apr 23, 2026
Careteq Limited has confirmed that all resolutions put to shareholders at its general meeting held on 23 April 2026 were passed. The approval of every resolution signals solid shareholder support for the company’s current strategy and govern...
Careteq Completes Sale of Embedded Health Unit to Fund Platform Growth and Strengthen Balance Sheet
Apr 8, 2026
Careteq Limited has completed the sale of its wholly owned subsidiary Embedded Health Solutions to Nationwide Investments Holdings for $5 million, subject to customary adjustments of about $990,000 for working capital and employee entitlements. A ...
Careteq Sets Fully Virtual General Meeting for April 2026
Mar 24, 2026
Careteq Limited has called a virtual general meeting of shareholders for 23 April 2026, instructing investors on how to participate and vote online via the Automic platform. The company is emphasizing early proxy lodgement, electronic communicatio...
Careteq Raises New Equity Through Share Issue at $0.005
Mar 18, 2026
Careteq Limited has issued 38,632,636 fully paid ordinary shares at $0.005 per share, expanding its share capital via a placement conducted without a disclosure document under the Corporations Act. The company confirmed it is compliant with its fi...
Careteq Seeks ASX Quotation for 38.6 Million New Shares
Mar 18, 2026
Careteq Ltd. has applied to the Australian Securities Exchange for quotation of 38,632,636 ordinary fully paid shares, with an issue date of 19 March 2026. The new securities, linked to transactions previously flagged to the market, will expand th...
Careteq Shareholders Approve Resolution at 2026 General Meeting
Mar 12, 2026
Careteq Limited has confirmed that shareholders passed the single resolution put to its 2026 General Meeting held in Melbourne on 13 March, with proxy voting details recorded in line with Australian corporate and listing requirements. The approval...
DMX Asset Management Exits Substantial Shareholding in Careteq
Mar 11, 2026
Careteq Limited has disclosed that DMX Asset Management Limited has ceased to be a substantial shareholder in the company. According to the notice, DMX Asset Management sold 33,109,651 ordinary shares for consideration of $231,767.56, resulting in...
Careteq Plans Major Share Placement to Raise Fresh Capital
Mar 10, 2026
Careteq Ltd. has announced a proposed issue of up to 401,367,364 ordinary fully paid shares via a placement or similar capital-raising structure, with an expected issue date of 23 April 2026. The substantial size of the planned equity issue signal...
Careteq Plans Major Share Placement to Raise New Equity
Mar 10, 2026
Careteq Ltd. has announced a proposed issue of up to 38,632,636 ordinary fully paid shares under a placement or similar capital-raising structure, with the new securities expected to be issued on 18 March 2026. The move signals an effort to streng...
Careteq Plans Issue of 50 Million New Options to Expand Capital Base
Mar 10, 2026
Careteq Limited has lodged an Appendix 3B with the ASX outlining a proposed issue of up to 50,000,000 options as part of a placement or similar capital-raising transaction. The options form a new class of securities, with the proposed issue date s...
Careteq Seeks Trading Halt Ahead of Share Placement Equity Raising
Mar 8, 2026
Careteq Ltd., an ASX-listed company trading under the ticker CTQ and headquartered in Melbourne, has requested a halt in trading of its securities while it prepares a capital raising via share placement. The announcement does not disclose the size...
Careteq Half-Year Loss Widens as Revenue Declines and NTA Stays Negative
Feb 26, 2026
Careteq Limited reported a challenging first half for the period ended 31 December 2025, with revenue from ordinary activities from continuing operations down 18.0% to $51,003 and no dividends declared or paid. The company’s comprehensive lo...
Careteq Raises Capital Through $0.01 Share Issue Under Secondary Trading Provisions
Feb 24, 2026
Careteq Limited has issued 20,432,192 new fully paid ordinary shares at an issue price of $0.01 per share, expanding its capital base without providing a prospectus or other disclosure document to investors. The company confirmed it is compliant w...
Careteq to Sell Embedded Health Solutions for $5m to Refocus on HMR Platform and Balance Sheet
Feb 5, 2026
Careteq has signed a binding agreement to sell its wholly owned subsidiary Embedded Health Solutions to private investment vehicle Nationwide Investments Holdings for $5 million in cash, subject to standard price adjustments and shareholder approv...
Careteq narrows cash outflows as aged‑care platform footprint and pipeline expand
Jan 30, 2026
Careteq Limited reported a disciplined cash performance for the quarter ended 31 December 2025, with cash receipts of $2.1 million for the quarter and $4.02 million for the first half of FY26, and a minimal underlying operating cash outflow of $0....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.